Po-ju Lin
Chang-hua, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Fecal Immunochemical Test Screening Status, Stage Distribution, and Overall Survival in Colorectal Cancer: A Propensity Score-Matched Cohort Study from a Regional Hospital in Taiwan.
Journal: Diagnostics (Basel, Switzerland)
Published: May 23, 2026
Corrigendum to "Massive nasal bleeding in nasopharyngeal carcinoma: incidence, risk predictors, and survival impact" [Oral Oncol. 167 (2025) 107456].
Journal: Oral oncology
Published: July 05, 2025
Massive nasal bleeding in nasopharyngeal Carcinoma: Incidence, risk Predictors, and survival impact: Running title: Massive nasal bleeding in NPC.
Journal: Oral oncology
Published: April 24, 2025
Magnolol Induces Apoptosis and Suppresses Immune Evasion in Non-small Cell Lung Cancer Xenograft Models.
Journal: Anticancer research
Published: July 25, 2024
Comparison the acute toxicity of two different induction chemotherapy schedules with cisplatin and fluorouracil in nasopharyngeal carcinoma patients.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 22, 2022
Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
Journal: Head & neck
Published: August 17, 2021
Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy.
Journal: Scientific reports
Published: October 29, 2020
Comparison the clinical outcomes with altered versus conventional fractionated radiotherapy plus concurrent chemotherapy for advanced nasopharyngeal carcinoma.
Journal: Head & neck
Published: April 13, 2017
Comparison Long-term Outcome of Definitive Radiotherapy plus Different Chemotherapy Schedules in Patients with Advanced Nasopharyngeal Carcinoma.
Journal: Scientific reports
Published: April 12, 2017
Prognostic impact of adjuvant chemotherapy in high-risk nasopharyngeal carcinoma patients.
Journal: Oral oncology
Published: July 15, 2016
Last Updated: 09/26/2026